TY - JOUR AU - Lichtenberg, F. R. PY - 2005 DA - 2005// TI - The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001 JO - Int J Health Care Finance Econ VL - 5 UR - https://doi.org/10.1007/s10754-005-6601-7 DO - 10.1007/s10754-005-6601-7 ID - Lichtenberg2005 ER - TY - STD TI - Lichtenberg FR. The impact of cardiovascular drug innovation on the longevity of elderly residents of Switzerland 2003-2012. Nordic J Health Econ. 2015; https://doi.org/10.5617/njhe.1291. ID - ref2 ER - TY - STD TI - Pavic M, Pfeil AM, Szucs TD. Estimating the potential annual welfare impact of innovative drugs in use in Switzerland. Front Public Health. 2014;2(48). https://doi.org/10.3389/fpubh.2014.00048. ID - ref3 ER - TY - JOUR AU - Reich, O. AU - Weins, C. AU - Schsterschitz, C. AU - Thöni, M. PY - 2012 DA - 2012// TI - Exploring the disparities of regional health care expenditures in Switzerland. Some empirical evidence JO - Eur J Health Econ VL - 13 UR - https://doi.org/10.1007/s10198-011-0299-x DO - 10.1007/s10198-011-0299-x ID - Reich2012 ER - TY - JOUR AU - Huskamp, H. A. AU - O'Malley, A. J. AU - Horvitz-Lennon, M. AU - Taub, A. L. AU - Berndt, E. R. AU - Donohue, J. M. PY - 2013 DA - 2013// TI - How quickly do physicians adopt new drugs? The case of second-generation antipsychotics JO - Psychiatr Serv VL - 64 UR - https://doi.org/10.1176/appi.ps.201200186 DO - 10.1176/appi.ps.201200186 ID - Huskamp2013 ER - TY - JOUR AU - Lubloy, A. PY - 2014 DA - 2014// TI - Factors affecting the uptake of new medicines: a systematic literature review JO - BMC Health Serv Res VL - 14 UR - https://doi.org/10.1186/1472-6963-14-469 DO - 10.1186/1472-6963-14-469 ID - Lubloy2014 ER - TY - STD TI - Federal Office of Public Health. Specialities list. Bern, 2017. https://www.bag.admin.ch/bag/fr/home/themen/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/Arzneimittel/Referenzdokumente-zur-Spezialitaetenliste.html. Accessed 19 Dec 2017. UR - https://www.bag.admin.ch/bag/fr/home/themen/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/Arzneimittel/Referenzdokumente-zur-Spezialitaetenliste.html ID - ref7 ER - TY - JOUR AU - Aronson, J. K. PY - 2008 DA - 2008// TI - Something new every day: defining innovation and innovativeness in drug therapy JO - J Ambulatory Care Manage VL - 31 UR - https://doi.org/10.1097/01.JAC.0000304100.38120.b2 DO - 10.1097/01.JAC.0000304100.38120.b2 ID - Aronson2008 ER - TY - JOUR AU - Cohen, J. AU - Cabanilla, L. AU - Sosnov, J. PY - 2006 DA - 2006// TI - Role of follow-on drugs and indications on the WHO essential drug list JO - J Clin Pharm Ther VL - 31 UR - https://doi.org/10.1111/j.1365-2710.2006.00777.x DO - 10.1111/j.1365-2710.2006.00777.x ID - Cohen2006 ER - TY - JOUR AU - Andrade, L. F. AU - Sermet, C. AU - Pichetti, S. PY - 2016 DA - 2016// TI - Entry time effects and follow-on drug competition JO - Eur J Health Econ VL - 17 UR - https://doi.org/10.1007/s10198-014-0654-9 DO - 10.1007/s10198-014-0654-9 ID - Andrade2016 ER - TY - JOUR AU - Vande Griend, J. P. AU - Marcum, Z. A. AU - Linnebur, S. A. PY - 2012 DA - 2012// TI - A year in review: new drugs for older adults in 2011 JO - Am J Geriatr Pharmacother VL - 10 UR - https://doi.org/10.1016/j.amjopharm.2012.05.003 DO - 10.1016/j.amjopharm.2012.05.003 ID - Vande Griend2012 ER - TY - JOUR AU - Shuchi, M. PY - 2015 DA - 2015// TI - Strategies for drug patent ever-greening in the pharmaceutical industry JO - Int J Pharm Sci Bus Manage VL - 3 ID - Shuchi2015 ER - TY - STD TI - Wertheimer AI, Santella TM. Pharmacoevolution: the advantages of incremental innovation. IPN Working Papers on Intellectual Property, Innovation and Health. London: International Policy Press a division of International Policy Network; 2004. ID - ref13 ER - TY - JOUR AU - Lexchin, J. PY - 2015 DA - 2015// TI - Health Canada's use of its priority review process for new drugs: a cohort study JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2014-006816 DO - 10.1136/bmjopen-2014-006816 ID - Lexchin2015 ER - TY - STD TI - Kesselheim AS, Wang B, Avorn J. Defining “innovativeness” in drug development: a systematic review. Clinical Pharmacology & Therapeutics. 2013;94(3):336–48. ID - ref15 ER - TY - STD TI - WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research. Norwegian Institute of Public Health, Oslo. 2017. https://www.whocc.no. Accessed 19 Dec 2017. UR - https://www.whocc.no ID - ref16 ER - TY - STD TI - Scott Morton F, Kyle M. Markets for Pharmaceutical Products. In: Pauly MV, Mcguire TG, Barros PP, editors. Handbook of health economics. North Holland: Elsevier; 2011. p. 763–823. ID - ref17 ER - TY - JOUR AU - Dubois, P. AU - de Mouzon, O. AU - Scott-Morton, F. AU - Seabright, P. PY - 2015 DA - 2015// TI - Market size and pharmaceutical innovation JO - RAND J Econ VL - 46 UR - https://doi.org/10.1111/1756-2171.12113 DO - 10.1111/1756-2171.12113 ID - Dubois2015 ER - TY - STD TI - Federal Office of Public Health. Supply categories for medicinal products. Bern, 2017. https://www.bag.admin.ch/bag/en/home/themen/mensch-gesundheit/biomedizin-forschung/heilmittel/abgabe-von-arzneimitteln.html. Accessed 19 Dec 2017. UR - https://www.bag.admin.ch/bag/en/home/themen/mensch-gesundheit/biomedizin-forschung/heilmittel/abgabe-von-arzneimitteln.html ID - ref19 ER - TY - JOUR AU - Decollogny, A. AU - Eggli, Y. AU - Halfon, P. AU - Lufkin, T. M. PY - 2011 DA - 2011// TI - Determinants of generic drug substitution in Switzerland JO - BMC Health Serv Res VL - 11 UR - https://doi.org/10.1186/1472-6963-11-17 DO - 10.1186/1472-6963-11-17 ID - Decollogny2011 ER - TY - JOUR AU - Hirschman, A. O. PY - 1964 DA - 1964// TI - The paternity of an index JO - Am Econ Rev VL - 54 ID - Hirschman1964 ER - TY - STD TI - Rasbash J, William JB. Non-Hierarchical Multilevel Models. In: Deleeuw J, Meijer Erik, editors. Handbook of Multilevel Analysis. Berlin: Springer; 2008. p. 301-334. ID - ref22 ER - TY - JOUR AU - Leckie, G. AU - Charlton, C. PY - 2012 DA - 2012// TI - Runmlwin: a program to run the MLwiN multilevel Modeling software from within Stata JO - J Stat Softw VL - 52 UR - https://doi.org/10.18637/jss.v052.i11 DO - 10.18637/jss.v052.i11 ID - Leckie2012 ER - TY - STD TI - Browne WJ. MCMC estimation in MLwiN Version 2.32. Bristol: Centre for Multilevel Modelling, University of Bristol; 2015. ID - ref24 ER - TY - STD TI - Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. 2nd edition. Advanced Quantitative Techniques in the Social Sciences Series. London: SAGE Publications Inc; 2002. ID - ref25 ER - TY - STD TI - Deleeuw J, Meijer E. Handbook of Multilevel Analysis. Berlin: Springer; 2008. ID - ref26 ER - TY - JOUR AU - Manning, W. G. PY - 1998 DA - 1998// TI - The logged dependent variable, heteroscedasticity, and the retransformation problem JO - J Health Econ VL - 17 UR - https://doi.org/10.1016/S0167-6296(98)00025-3 DO - 10.1016/S0167-6296(98)00025-3 ID - Manning1998 ER - TY - JOUR AU - Schemper, M. PY - 2003 DA - 2003// TI - Predictive accuracy and explained variation JO - Stat Med VL - 22 UR - https://doi.org/10.1002/sim.1486 DO - 10.1002/sim.1486 ID - Schemper2003 ER - TY - JOUR AU - Chao Yi-Chun, E. AU - Zhao, Y. AU - Kupper, L. L. AU - Nylander-French, L. A. PY - 2008 DA - 2008// TI - Quantifying the relative importance of predictors in multiple linear regression analyses of public health studies JO - J Occup Environ Hyg VL - 8 UR - https://doi.org/10.1080/15459620802225481 DO - 10.1080/15459620802225481 ID - Chao Yi-Chun2008 ER - TY - JOUR AU - Neuhaus, J. M. AU - Kalbfleisch, J. D. PY - 1998 DA - 1998// TI - Between- and within-cluster covariate effects in the analysis of clustered data JO - Biometrics VL - 55 ID - Neuhaus1998 ER - TY - JOUR AU - Begg, M. D. AU - Parides, M. K. PY - 2003 DA - 2003// TI - Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data JO - Stat Med VL - 22 UR - https://doi.org/10.1002/sim.1524 DO - 10.1002/sim.1524 ID - Begg2003 ER - TY - JOUR AU - Cole, T. J. PY - 2000 DA - 2000// TI - Sympercents: symmetric percentage differences on the 100 loge scale simplify the presentation of log transformed data JO - Stat Med VL - 19 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Cole2000 ER - TY - JOUR AU - Blozik, E. AU - Rapold, R. AU - von Overbeck, J. AU - Reich, O. PY - 2013 DA - 2013// TI - Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland JO - Drugs Aging VL - 30 UR - https://doi.org/10.1007/s40266-013-0073-0 DO - 10.1007/s40266-013-0073-0 ID - Blozik2013 ER - TY - STD TI - Tobin L, de Almedia Neto AC, Wutzke S, Patterson C, Mackson J, Weekes L, Williamson M. Influences on the prescribing of new drugs. Aust Fam Physician. 2008;37(1-2):78–83. ID - ref34 ER - TY - JOUR AU - Picton, C. AU - Loughrey, C. AU - Webb, A. PY - 2016 DA - 2016// TI - The need for a prescribing competency framework to address the burden of complex polypharmacy among multiple long-term conditions JO - Clin Med VL - 16 UR - https://doi.org/10.7861/clinmedicine.16-5-470 DO - 10.7861/clinmedicine.16-5-470 ID - Picton2016 ER - TY - JOUR AU - Wertli, M. M. AU - Reich, O. AU - Signorell, A. AU - Burgstaller, J. M. AU - Steurer, J. AU - Held, U. PY - 2017 DA - 2017// TI - Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims JO - BMC Health Serv Res VL - 17 UR - https://doi.org/10.1186/s12913-017-2086-6 DO - 10.1186/s12913-017-2086-6 ID - Wertli2017 ER - TY - JOUR AU - Murshid, M. A. AU - Mohaidin, Z. PY - 2017 DA - 2017// TI - Models and theories of prescribing decisions: a review and suggested a new model JO - Pharm Pract VL - 15 UR - https://doi.org/10.18549/PharmPract.2017.02.990 DO - 10.18549/PharmPract.2017.02.990 ID - Murshid2017 ER -